Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jan;42(1):194-6.
doi: 10.1128/AAC.42.1.194.

Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia

P M Roblin  1 , M R Hammerschlag
Affiliations

Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia

P M Roblin et al. Antimicrob Agents Chemother. 1998 Jan.

Abstract

Chlamydia pneumoniae was eradicated from the nasopharynges of 26 of 33 (78.8%) evaluable children and adults with community-acquired pneumonia who were treated with azithromycin. We tested 55 isolates of C. pneumoniae obtained from 46 of these patients against azithromycin. The MIC at which 90% of the isolates were inhibited and the minimal chlamydiacidal concentration at which 90% of strains tested were killed of azithromycin for these isolates were both 0.5 microg/ml. Seven patients remained culture positive after treatment. The MICs of azithromycin for isolates from two patients increased fourfold after therapy. However, all the patients with persistent infection improved clinically. Further studies of treatment of C. pneumoniae infection, utilizing culture, are needed both to assess efficacy and to monitor for the possible development of antibiotic resistance.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Anderson, G., T. S. Esmonde, S. Coles, J. Macklin, and C. Carnegie. 1991. A comparative study of clarithromycin and erythromycin stearate in community acquired pneumonia. J. Antimicrob. Chemother. 27(Suppl. A):117–124. - PubMed
    1. Block S, Hedrick J, Hammerschlag M R, Cassell G H, Craft C. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471–477. - PubMed
    1. Chien S M, Pichotta P, Stepman N, Chan C K. Treatment of community-acquired pneumonia. A multicenter, double blind, randomized study comparing clarithromycin to erythromycin. Chest. 1993;103:697–701. - PubMed
    1. Grayston J T, Campbell L A, Kuo C-C, Mordhorst C H, Saikku P, Thom D H, Wang S P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990;161:618–625. - PubMed
    1. Hammerschlag M R, Chirgwin K, Roblin P M, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis. 1992;14:178–182. - PubMed